A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Conditions
- Urinary Tract Infection
- Acute Pyelonephritis
Interventions
- DRUG: TBP-PI-HBr
- DRUG: Imipenem-cilastatin
- DRUG: Dummy Infusion
- DRUG: Dummy Tablets
Sponsor
Spero Therapeutics
Collaborators